Join BOPA
Back to news articles

[Updated] UK SACT Board: Good Practice Guidance for Immuno-Oncology Medicines

By BOPA Committee on 13th May 2024

UK SACT Board

 

Good Practice Guidance for Immuno-Oncology Medicines – May 2024

The UK SACT Board’s Good Practice Guidance for Immuno-Oncology Medicines has been updated.

This guideline is designed to give a practical framework for the safe introduction and ongoing use of immunotherapy in existing Systemic Anti-Cancer Therapy (SACT) services.

This guideline is available on the UK SACT Board publication page: https://www.uksactboard.org/publications

Latest News

By BOPA Executive Committee on 29th July 2026

Publication ALERT – Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation

BOPA Publication: Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation – Annette (Netty) Cracknell, Dharmisha Chauhan, Lisa Barrott, Emma…

Read article
By BOPA on 24th July 2026

Call for BOPA Award nominations – 1 week left!

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article
By BOPA Research Subcommittee on 14th July 2026

Record Abstract Submission for BOPA Annual Conference 2026

BOPA is thrilled to announce that we have received an incredible number of 235 abstracts for our annual conference 2026. The record number of abstract is testament to our continued…

Read article
By BOPA on 12th July 2026

Closing this week – The BOPA Training and Development Grant for BOPA Conference 2026

BOPA are offering (in collaboration with Gilead) 16 funded places to the BOPA 2026 Conference in London from 2-4th Oct 20265. Information can be found here – The BOPA Training and Development Grant…

Read article